COMMONWEALTH EQUITY SERVICES, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2023$6
-89.8%
48,638
-58.2%
0.00%
Q2 2023$59
-19.2%
116,367
-0.7%
0.00%
Q1 2023$73
-2.7%
117,244
+1.3%
0.00%
Q4 2022$75
-100.0%
115,744
-9.6%
0.00%
-100.0%
Q3 2022$220,000
+39.2%
128,0660.0%0.00%
Q2 2022$158,000
+59.6%
128,066
-15.9%
0.00%
Q1 2022$99,000
-42.4%
152,344
-3.9%
0.00%
Q4 2021$172,000
-35.8%
158,594
+7.4%
0.00%
-100.0%
Q3 2021$268,000
+53.1%
147,666
+122.7%
0.00%
Q2 2021$175,000
+8.0%
66,293
+46.6%
0.00%
Q1 2021$162,000
-3.0%
45,218
-32.0%
0.00%
-100.0%
Q4 2020$167,000
+42.7%
66,521
+42.8%
0.00%
Q3 2020$117,000
-14.0%
46,571
+12.3%
0.00%
-100.0%
Q2 2020$136,000
+30.8%
41,471
-2.4%
0.00%
Q1 2020$104,000
-48.3%
42,471
-0.7%
0.00%
-100.0%
Q4 2019$201,000
-4.3%
42,750
-13.1%
0.00%0.0%
Q3 2019$210,000
-32.0%
49,194
-7.3%
0.00%0.0%
Q2 2019$309,000
+39.2%
53,094
-7.9%
0.00%0.0%
Q1 2019$222,000
+86.6%
57,669
-9.4%
0.00%0.0%
Q4 2018$119,000
-42.0%
63,649
-0.8%
0.00%0.0%
Q3 2018$205,000
+9.0%
64,146
+2.9%
0.00%0.0%
Q2 2018$188,000
-16.8%
62,316
+7.9%
0.00%0.0%
Q1 2018$226,000
-5.4%
57,776
+0.0%
0.00%0.0%
Q4 2017$239,00057,7560.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 15,461,829$2,037,8690.36%
MSD Partners, L.P. 15,151,516$1,996,9700.16%
MSD Partners, L.P. 7,575,758$998,4850.08%
MAGNOLIA CAPITAL ADVISORS LLC 865,938$65,5520.03%
Allred Capital Management, LLC 253,000$33,3450.02%
CHIRON CAPITAL MANAGEMENT, LLC 77,023$10,1520.01%
Boxer Capital, LLC 1,100,000$144,9800.01%
GSA CAPITAL PARTNERS LLP 569,566$750.01%
Sugarloaf Wealth Management, LLC 75,500$9,9510.00%
Owen LaRue, LLC 11,825$1,5590.00%
View complete list of ZIOPHARM ONCOLOGY INC shareholders